Kazia Therapeutics Limited
Kazia Therapeutics Limited (KZIA) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
kzia · stock forecast · 2 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 2 Wall Street analysts in the past 3 months
Buy
2 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$25.00
Consensus
$21.50
+88.6% upside
Low
$18.00
Median: $21.5 · Last Close: $11.40
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$21.50
88.6% upside
High Target
$25
119.3%
Low Target
$18
57.9%
Current Price
$11.40
as of today
Based on analyst price targets, the KZIA stock price prediction for the next 12 months ranges from $18 to $25. The consensus KZIA price forecast of $21.50 implies 88.6% upside from the current price of $11.40.
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $10.83 | ↓ 5.00% |
1-day model range: $10.6–$11.06. Peak: $11.06 (-5.00%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · KZIA · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-01-28 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-12-12 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-10-02 | Maxim Group | Maintains | Buy→Buy |
| 2025-07-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-06-11 | Maxim Group | Maintains | Buy→Buy |
| 2024-07-12 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-04-11 | HC Wainwright & Co. | Upgrade ↑ | Neutral→Buy |
| 2022-08-02 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2022-08-02 | Maxim Group | Downgrade ↓ | Buy→Hold |
| 2021-10-14 | Maxim Group | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Kazia Therapeutics Limited (KZIA) stock. Of the recent 11 rating actions, 1 were upgrades and 2 were downgrades. 2 analysts currently cover KZIA.
Analyst Recommendation Trends
KZIA analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$0M
↓ 33.9% YoY
Revenue Next Year
$0M
↑ 21.9% YoY
EPS This Year
$-1.42
EPS Next Year
$-2.04
↑ 43.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast KZIA EPS of $-1.42 for the current fiscal year, based on estimates from 1 analysts. The KZIA revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The KZIA stock forecast is supported by two independent data sources: analyst consensus ratings from 2 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus KZIA price target is $21.50 (+88.6% upside), with an analyst consensus of Buy.
The KZIA short-term stock prediction for tomorrow is $10.83 (-5.00%).
Kazia Therapeutics Limited trades on NASDAQ under the ticker KZIA. The KZIA stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
KZIA forecast · 8 questionsAccording to 2 Wall Street analysts, the average 12-month KZIA price target is $21.50, with a high forecast of $25.00 and a low of $18.00. The median price target is shown in the chart above when available. This implies +88.6% potential upside from the current price of $11.40.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.